Literature DB >> 4023635

Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis.

I Julander.   

Abstract

Factors predictive of a fatal outcome were retrospectively studied in 248 patients admitted with Staphylococcus aureus septicemia during 1965-1982, 78 of whom had endocarditis. 77 patients were intravenous drug addicts and 47 of them had endocarditis. 48 patients (19.4%) died. The fatality rate in addicts and non-addicts from septicemia was 0% and 17.9% and from endocarditis 8.5% and 61.3%, respectively. After analyzing clinical and laboratory data available early in the course of the disease 4 risk factors were found both in septicemia and endocarditis: age greater than or equal to 60 yr, pre-existing cardiovascular disease, prior hospitalization within 30 days of onset of illness, and neurological symptoms and/or signs. In addition, in endocarditis a platelet count before therapy less than 100 X 10(9)/l and left-sided involvement were unfavourable prognostic factors.

Entities:  

Mesh:

Year:  1985        PMID: 4023635     DOI: 10.3109/inf.1985.17.issue-2.09

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.

Authors:  Dorothee Grumann; Eeva Ruotsalainen; Julia Kolata; Pentti Kuusela; Asko Järvinen; Vesa P Kontinen; Barbara M Bröker; Silva Holtfreter
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

2.  Septicemia and endocarditis, 1965-1980, in a Swedish university hospital for infectious diseases.

Authors:  I Julander
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  Bacteraemia due to Staphylococcus aureus.

Authors:  S Ladhani; O S Konana; S Mwarumba; M C English
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

4.  Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections.

Authors:  Dokyun Kim; Jun Sung Hong; Eun-Jeong Yoon; Hyukmin Lee; Young Ah Kim; Kyeong Seob Shin; Jeong Hwan Shin; Young Uh; Jong Hee Shin; Yoon Soo Park; Seok Hoon Jeong
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.

Authors:  Eeva Ruotsalainen; Kari Sammalkorpi; Janne Laine; Kaisa Huotari; Seppo Sarna; Ville Valtonen; Asko Järvinen
Journal:  BMC Infect Dis       Date:  2006-09-11       Impact factor: 3.090

6.  Antibiotic susceptibility patterns of Staphylococcus aureus strains isolated at the Yaounde Central Hospital, Cameroon: a retro prospective study.

Authors:  Michel Kengne; Olivier Fotsing; Thérèse Ndomgue; Julius Mbekem Nwobegahay
Journal:  Pan Afr Med J       Date:  2019-03-05

7.  Excess mortality and long-term disability from healthcare-associated staphylococcus aureus infections: a population-based matched cohort study.

Authors:  Chiu-Hsia Su; Shan-Chwen Chang; Jer-Jea Yan; Shu-Hui Tseng; Li-Jung Chien; Chi-Tai Fang
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

8.  Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.

Authors:  Hilmir Asgeirsson; Anders Thalme; Ola Weiland
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.